Discover 1,431 paid clinical trials in Quebec. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 1,431
Polymorphisms and Busulfan Pharmacokinetic Study
for
Children Who Receive a Stem Cell Transplantation With Busulfan IV,
Location: Montreal
Sponsor: University Hospital, Geneva
Sex: All
Age: 0 - 18
Code: NCT01257854
Recruiting
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
Location: Quebec, Hollywood FL, Royal Oak MI, Cincinnati OH,
Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Sex: All
Age: 18+
Code: NCT05459233
Recruiting
The PERFORM-TAVR Trial
for
Frail Elderly, Exercise, Dietary Supplements,
Location: Montreal
Sponsor: Jewish General Hospital
Sex: All
Age: 70+
Code: NCT03522454
Recruiting
Gastric Cancer Sentinel Lymph Node Mapping
for
Gastric Cancer, Sentinel Lymph Node, Early Gastric Cancer
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: All
Age: 0+
Code: NCT03049345
Recruiting
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
for
Multiple Myeloma
Location: Boston MA, New York NY, Montreal, Philadelphia PA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06106945
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer
for
Non-Muscle Invasive Bladder Cancer
Location: Levis, Quebec, Sherbrooke, Montreal, Toronto, London
Sponsor: CHU de Quebec-Universite Laval
Sex: Male
Age: 18+
Code: NCT05327647
Phase 2, Recruiting
High-intensity Interval Training Prescriptions to Reduce the Risk of Complications Linked to Type 2 Diabetes: the Role of Interval Length on Clinical Benefits and on Physiological Mechanisms
for
Diabetes Mellitus, Type 2
Location: Sherbrooke
Sponsor: Université de Sherbrooke
Sex: Female
Age: 60 - 70+
Code: NCT04986345
Recruiting
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).